Cargando…
Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound
Hepatocellular carcinoma (HCC) is a unique cancer entity that can be noninvasively diagnosed using imaging modalities without pathologic confirmation. In 2018, several major guidelines for HCC were updated to include hepatobiliary contrast agent magnetic resonance imaging (HBA-MRI) and contrast-enha...
Autores principales: | Park, Junghoan, Lee, Jeong Min, Kim, Tae-Hyung, Yoon, Jeong Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293611/ https://www.ncbi.nlm.nih.gov/pubmed/34955003 http://dx.doi.org/10.3350/cmh.2021.0361 |
Ejemplares similares
-
Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines
por: Kim, Tae-Hyung, et al.
Publicado: (2019) -
Three-dimensional imaging for hepatobiliary and pancreatic diseases: Emphasis on clinical utility
por: Kim, Soo Jin, et al.
Publicado: (2009) -
The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
por: Jeong, Woo Kyoung, et al.
Publicado: (2013) -
Liver Imaging and Hepatobiliary Contrast Media
por: Pastor, Catherine M., et al.
Publicado: (2018) -
Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
por: Yoon, Ja Kyung, et al.
Publicado: (2023)